Compounds > cp 65,526
Page last updated: 2024-09-03

cp 65,526 and paclitaxel

cp 65,526 has been researched along with paclitaxel in 3 studies

Compound Research Comparison

Studies
(cp 65,526)		Trials
(cp 65,526)		Recent Studies (post-2010)
(cp 65,526)		Studies
(paclitaxel)		Trials
(paclitaxel)		Recent Studies (post-2010) (paclitaxel)
651531,8745,72915,395

Protein Interaction Comparison

ProteinTaxonomycp 65,526 (IC50)paclitaxel (IC50)
Integrin beta-3Homo sapiens (human)0.034
Integrin alpha-V Homo sapiens (human)0.034
ATP-dependent translocase ABCB1Homo sapiens (human)2.598
Botulinum neurotoxin type A Clostridium botulinum5.2
UDP-glucuronosyltransferase 2B7Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1-6Homo sapiens (human)4.9
Substance-K receptorHomo sapiens (human)6.125
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1A4Homo sapiens (human)4.9
UDP-glucuronosyltransferase 2B10 Homo sapiens (human)4.9
Delta-type opioid receptorHomo sapiens (human)4.202
Tyrosine-protein kinase MerHomo sapiens (human)4.9
Tubulin beta-3 chainHomo sapiens (human)0.0082
Beta-tubulin Leishmania donovani1
Nucleotide-binding oligomerization domain-containing protein 2Homo sapiens (human)7.9433
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.26
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.28

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambudkar, SV; Barnett, D; Bates, SE; Finley, EM; Fojo, T; Oldham, RK; Robey, RW; Shukla, S1
Ambudkar, SV; Limtrakul, P; Ohnuma, S; Pintha, K; Pitchakarn, P; Pompimon, W1
Abel, B; Ambudkar, SV; Durell, SR; Jacobson, KA; Murakami, M; Tosh, DK; Vahedi, S1

Trials

1 trial(s) available for cp 65,526 and paclitaxel

ArticleYear
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).
    Biochemical pharmacology, 2008, Mar-15, Volume: 75, Issue:6

    Topics: Adenosine Triphosphatases; Alkaloids; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Factors; Biological Transport; Cell Line; Cell Line, Tumor; Cyclosporins; Depsipeptides; Fluorescent Dyes; Fluorouracil; Humans; Insecta; Multidrug Resistance-Associated Proteins; Neoplasms; Paclitaxel; Prazosin; Quinolines; Rhodamine 123; Verapamil; Vinblastine

2008

Other Studies

2 other study(ies) available for cp 65,526 and paclitaxel

ArticleYear
Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance.
    The Journal of nutritional biochemistry, 2012, Volume: 23, Issue:1

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding Sites; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluoresceins; Humans; Molecular Structure; Momordica charantia; Paclitaxel; Plant Leaves; Prazosin; Rhodamine 123; Triterpenes; Uterine Cervical Neoplasms; Vinblastine

2012
Evidence for the Interaction of A
    Molecular pharmacology, 2019, Volume: 96, Issue:2

    Topics: Adenosine A3 Receptor Agonists; ATP Binding Cassette Transporter, Subfamily B; Azides; Binding Sites; HeLa Cells; Humans; Models, Molecular; Molecular Docking Simulation; Paclitaxel; Prazosin; Structure-Activity Relationship; Verapamil

2019